Expression and Function of Immune Receptors in Pediatric Acute Lymphoblastic Leukemia

Simple item page
dc.contributor.advisorStephen O. Mathew
dc.contributor.committeeMemberPorunelloor A. Mathew
dc.contributor.committeeMemberW. Paul Bowman
dc.creatorPowers, Sheila B.
dc.date.accessioned2019-08-22T19:30:07Z
dc.date.available2019-08-22T19:30:07Z
dc.date.issued2016-12-01
dc.date.submitted2018-12-13T14:12:12-08:00
dc.description.abstractAcute lymphoblastic leukemia (ALL) is a cancer that mainly affects children around the age of five. Due to current treatments, 80-90% of children achieve long-term remission. However, because of the current treatments, which include chemotherapy and CNS-directed radiation, these children may experience late effects which impact growth and development. Even though survival rate is high, quality of life can be greatly reduced for some of the survivors. Natural Killer (NK) cells are cells of the innate immune system that are important in fighting cancer and virally-infected cells. They have been a subject of interest in ALL because ALL of the B cell lineage is particularly resistant to NK cell killing. NK cells get activated by their surface receptors and their ligands on target cells. In B cell ALL, the NK cells do not appear to get the proper activating signals and this has been determined to be one reason this cancer is able to thrive. Our lab has cloned three immune receptors, 2B4 (CD244), CS1 (CRACC, CD319) and LLT1 (CLEC2D), that are expressed on NK cells as well as other immune cells. These receptors have been shown to play an important role in NK cell activation. Two other receptors, NKp30 and NKp46, are well-known activating receptors that have also been implicated in ALL. In this project I compared the mRNA and surface protein receptor expression of immune receptors between healthy subjects and ALL subjects. Altered expression of immune receptors was observed in ALL subjects. In particular, a significant decrease in mRNA expression of 2B4, LLT1 and NKp30 was observed in ALL subjects at diagnosis compared to healthy subjects. mRNA expression of CS1 was increased significantly after chemotherapy treatment. In contrast, NKp46 mRNA expression was significantly increased in ALL subjects as compared to healthy subjects. Cell surface protein expression of CS1 was significantly upregulated on T cells and monocytes and LLT1 on NK cells of ALL subjects at diagnosis. Interestingly, NKp30 was overexpressed on B cells, T cells, monocytes and NKp46 was overexpressed on T cells and monocytes but not on NK cells of ALL subjects at diagnosis. I also detected a significant increase of soluble CS1and BAT-3 in ALL subjects at diagnosis between the ages of 1-11 yrs. Also, soluble CD48 was significantly increased in ALL subjects after chemotherapy treatments. Future mechanistic studies may shed more light in the immune dysfunction in ALL ultimately contributing to better treatment options for patients with pediatric ALL.
dc.format.mimetypeapplication/pdf
dc.identifier.urihttps://hdl.handle.net/20.500.12503/25925
dc.language.isoen
dc.provenance.legacyDownloads5
dc.subjectMedical Sciences
dc.subjectMedicine and Health Sciences
dc.subjectNatural Killer Cells
dc.subjectLeukemia
dc.subjectALL
dc.subjectacute lymphoblastic leukemia
dc.subjectimmunotherapy
dc.subject2B4
dc.subjectCS1
dc.subjectLLT1
dc.titleExpression and Function of Immune Receptors in Pediatric Acute Lymphoblastic Leukemia
dc.typeThesis
dc.type.materialtext
thesis.degree.departmentGraduate School of Biomedical Sciences
thesis.degree.disciplineBiomedical Sciences
thesis.degree.grantorUniversity of North Texas Health Science Center at Fort Worth
thesis.degree.nameMaster of Science

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
2016_12_gsbs_Powers_Sheila_thesis.pdf
Size:
1.21 MB
Format:
Adobe Portable Document Format
Download

Collections

School of Biomedical Sciences
Theses and Dissertations